GlassScriptPhysician profile
Christopher M Maulucci
NPI 1386770402
$134,255.93
in general payments reported to CMS, 2019-2025
15 companies · $11K in 2025
The $11K reported for 2025 was more than what 86% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $71K · 2020: $6,277 · 2021: $11K · 2022: $11K · 2023: $23K · 2024: $1,486 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $19K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $8,400 · Travel and Lodging: $3,897 · Food and Beverage: $3,166.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $19,212.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $8,400.00 |
| Travel and Lodging | $3,896.74 |
| Food and Beverage | $3,165.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $132,458.46 | 2019-2025 | Rise-L . Rise-L A/L, Quartex, Tlif |
| Biogen, INC. | $813.14 | 2019-2023 | Tysabri, Vumerity |
| Medtronic, INC. | $483.08 | 2023-2024 | T2 Stratosphere Expandable Corpectomy System, Unid_pass, Intellis Adaptivestim |
| Providence Medical Technology, INC. | $147.35 | 2025 | |
| Depuy Synthes Sales INC. | $115.20 | 2023-2024 | Sentio, Cerebase, Cerepak Uniform |
| Lundbeck LLC | $41.59 | 2020-2023 | Vyepti |
| Argenx US, INC. | $37.33 | 2022-2023 | Vyvgart |
| Kerecis Limited | $31.93 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Dilon Technologies, INC. | $28.73 | 2025 | Hemoblast Bellows |
| Medtronic USA, INC. | $28.47 | 2020 | |
| Alon Medical Technology | $20.70 | 2024 | |
| Stryker Corporation | $18.88 | 2019 | |
| Adamas Pharmaceuticals, INC. | $17.62 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $13.45 | 2023 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Maulucci listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.